Copyright & Licensing

The Journal of Cancer and Translational Oncology (JCTO) is committed to promoting open access publishing while ensuring proper recognition and protection of authors’ intellectual contributions.

Copyright Policy

Authors publishing in the journal retain the copyright of their work. By submitting and publishing in JCTO, authors grant the journal the right to publish, distribute, and archive their work in online and digital formats.

All published content remains the intellectual property of the authors. Proper citation and attribution must always be provided when the work is used, shared, or reproduced in any form.

Licensing Terms

All articles published in the journal are made freely available under an open-access license, which permits:

  • Free reading and downloading of articles

  • Sharing and redistribution for academic and non-commercial purposes

  • Educational and research use of published content

  • Reproduction in any medium with proper citation and acknowledgment

Commercial reuse of published material may require prior permission from the authors or the editorial office of the journal.

Author Rights

Authors retain the right to:

  • Reuse their published work in future research, books, or academic presentations

  • Share their articles in institutional repositories and personal websites

  • Use their work for teaching and non-commercial scholarly purposes with proper citation

Publisher Rights

The journal retains the right to:

  • Publish, archive, and distribute accepted manuscripts

  • Maintain the integrity of the version of record

  • Assign DOIs and metadata for indexing and long-term accessibility

Open Access Commitment

The Journal of Cancer and Translational Oncology fully supports open access publishing to ensure that cancer research and clinical findings are freely accessible to researchers, clinicians, and the global scientific community without financial or access barriers.

All published articles remain permanently accessible online to promote global knowledge sharing, scientific collaboration, and advancements in cancer diagnosis and treatment.